Skip to main content

Find Clinical Trials

Home
Conditions
Extramedullary Disease in Multiple Myeloma

Clinical trial condition

Extramedullary Disease in Multiple Myeloma

Explore clinical trials studying Extramedullary Disease in Multiple Myeloma. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Extramedullary Disease in Multiple Myeloma trial results

Recruiting

Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease

NCT06627751

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Disease in Multiple Myeloma, +15 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"

NCT07382739

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Elranatamab, +19 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

NCT06572605

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Disease in Multiple Myeloma, +13 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details